Quest Diagnostics Incorporated (NYSE:DGX) Q1 2024 Earnings Conference Call April 23, 2024 8:30 AM ET Company Participants Jim Davis - Chairman, Chief Executive Officer, President Sam Samad - Chief Financial Officer Shawn Bevec - Vice President of Investor Relations Conference Call Participants Patrick Donnelly - Citi Ann Hynes - Mizuho Securities Kevin Caliendo - UBS Taji Phillips - Jefferies Erin Wright - Morgan Stanley Michael Cherny - Leerink Partners Jack Meehan - Nephron Research Elizabeth Anderson - ...

Quest Diagnostics Incorporated’s (DGX) first-quarter 2024 adjusted earnings per share (EPS) of $2.04 beat the Zacks Consensus Estimate by 9.7%. However, the metric came in line with the year-ago adjusted figure.Certain one-time expenses, like the ones related to amortization expenses, certain restructuring and integration charges, other expenses and excess tax benefits associated with stock-based compensations, were excluded from the quarter’s adjusted figures.GAAP earnings came in at $1.72 per share, down ...

Quest Diagnostics (DGX) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.68%. A quarter ago, it was expected that this medical laboratory operator would post earnings of $2.14 per share when it actually produced earnings of $2.15, delivering a surprise of 0.47%.Over the last four qua ...

Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 Exhibit 99.1 "In addition, our Invigorate initiative, which includes ongoing investments in automation and AI, continued to improve productivity as well as service levels and quality. Given the strength of our business, we are raising our revenue and adjusted earnings guidance for the full year," Mr. Davis said. | | | | | Three Months Ended March 31, | | | --- | --- | --- | --- | --- | --- | | | | 2024 | | 202 ...

First quarter revenues of $2.37 billion, up 1.5% from 2023 First quarter reported diluted earnings per share ("EPS") of $1.72, down 3.4% from 2023; and adjusted diluted EPS of $2.04, flat with 2023 Full year 2024 revenues now expected to be between $9.40 billion and $9.48 billion; reported diluted EPS now expected to be between $7.57 and $7.82; and adjusted diluted EPS expected to be between $8.72 and $8.97 SECAUCUS, N.J., April 23, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leadin ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Quest Diagnostics (DGX) reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 23. ...

Quest Diagnostics (DGX) is set to release first-quarter 2024 results on Apr 23 before the opening bell.The company posted adjusted earnings per share (EPS) of $2.15 in the last reported quarter, which surpassed the Zacks Consensus Estimate by 0.47%. Quest Diagnostics beat earnings estimates in each of the trailing four quarters, the average surprise being 2.13%.Let’s look at how things have shaped up before this announcement.Factors at PlayBase BusinessIn the first quarter of 2024, the company is likely to ...

Quest Diagnostics Incorporated (DGX) entered into a research collaboration with Broad Clinical Labs — the expert in whole genome sequencing (WGS). The collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.For investors’ note, Broad Clinical Labs is a pioneer in human whole genome sequencing, having sequenced more than 600,000 genomes as part of its aim to expedite the knowledge and diagnosis of human disease.M ...

SECAUCUS, N.J., March 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2024 financial results on Tuesday, April 23, 2024, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.   The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode ...

Quest Diagnostics, Incorporated (DGX) recently collaborated with Instacart to improve both food access and healthy eating habits for underserved communities across the United States. To reduce the impact of social determinants of health on care — Pack Health, a Quest Diagnostics company — is offering grocery delivery services via Instacart to those enrolled in its coaching programs.Through this collaboration, both companies are offering user-friendly solutions that leverage Instacart's reach, scale, selecti ...